Abstract
As defined by the UK Working Party’s diagnostic criteria [1], atopic dermatitis (AD), also known as atopic eczema, is a relapsing, chronic, inflammatory, cutaneous disorder that occurs mainly in childhood and sometimes persists into adulthood [2]. AD currently affects 10–30 % of children worldwide [3, 4]. It is a public health concern because of its prevalence, cost, and impact on quality of life. Atopic eczema in children can indeed have a profound effect on quality of life, causing major sleep disruption for the child and family and interfering with normal development, education, and play. Thus, the broad impact of AD warrants optimization of relevant support services.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Williams HC, Burney PG, Pembroke AC, Hay RJ (1994) The U.K. working party’s diagnostic criteria for atopic dermatitis. III. Independent hospital validation. Br J Dermatol 131(3):406–416
Silverberg JI, Hanifin JM (2013) Adult eczema prevalence and associations with asthma and other health and demographic factors: a US population-based study. J Allergy Clin Immunol 132(5):1132–1138
Bieber T (2008) Atopic dermatitis. N Engl J Med 358(14):1483–1494, 3 avr
Spergel JM (2010) Epidemiology of atopic dermatitis and atopic march in children. Immunol Allergy Clin North Am 30(3):269–280
Tan X, Feldman SR, Chang J, Balkrishnan R (2012) Topical drug delivery systems in dermatology: a review of patient adherence issues. Expert Opin Drug Deliv 9(10):1263–1271
Koehler AM, Maibach HI (2001) Electronic monitoring in medication adherence measurement. Implications for dermatology. Am J Clin Dermatol 2(1):7–12
Krejci-Manwaring J, Tusa MG, Carroll C, Camacho F, Kaur M, Carr D et al (2007) Stealth monitoring of adherence to topical medication: adherence is very poor in children with atopic dermatitis. J Am Acad Dermatol 56(2):211–216
Yentzer BA, Camacho FT, Young T, Fountain JM, Clark AR, Feldman SR (2010) Good adherence and early efficacy using desonide hydrogel for atopic dermatitis: results from a program addressing patient compliance. J Drugs Dermatol JDD 9(4):324–329
Furue M, Onozuka D, Takeuchi S, Murota H, Sugaya M, Masuda K et al (2015) Poor adherence to oral and topical medication in 3096 dermatological patients as assessed by the Morisky Medication Adherence Scale-8. Br J Dermatol 172(1):272–275
Hix E, Gustafson CJ, O’Neill JL, Huang K, Sandoval LF, Harrison J et al (2013) Adherence to a five day treatment course of topical fluocinonide 0.1% cream in atopic dermatitis. Dermatol Online J 19(10):20029
Yentzer BA, Ade RA, Fountain JM, Clark AR, Taylor SL, Borgerding E et al (2010) Improvement in treatment adherence with a 3-day course of fluocinonide cream 0.1% for atopic dermatitis. Cutis 86(4):208–213
Torrelo A, Ortiz J, Alomar A, Ros S, Pedrosa E, Cuervo J (2013) Health-related quality of life, patient satisfaction, and adherence to treatment in patients with moderate or severe atopic dermatitis on maintenance therapy: the CONDA-SAT study. Actas Dermosifiliogr 104(5):409–417
Ortiz de Frutos FJ, Torrelo A, de Lucas R, González MA, Alomar A, Vera Á et al (2014) Patient perspectives on triggers, adherence to medical recommendations, and disease control in atopic dermatitis: the DATOP study. Actas Dermosifiliogr 105(5):487–496
Krueger KP, Berger BA, Felkey B (2005) Medication adherence and persistence: a comprehensive review. Adv Ther 22(4):313–356
Osterberg L, Blaschke T (2005) Adherence to medication. N Engl J Med 353(5):487–497
Gupta G, Mallefet P, Kress DW, Sergeant A (2009) Adherence to topical dermatological therapy: lessons from oral drug treatment. Br J Dermatol 161(2):221–227
Beattie PE, Lewis-Jones MS (2003) Parental knowledge of topical therapies in the treatment of childhood atopic dermatitis. Clin Exp Dermatol 28(5):549–553
Fenerty SD, O’Neill JL, Gustafson CJ, Feldman SR (2013) Maternal adherence factors in the treatment of pediatric atopic dermatitis. JAMA Dermatol 149(2):229–231
Ohya Y, Williams H, Steptoe A, Saito H, Iikura Y, Anderson R et al (2001) Psychosocial factors and adherence to treatment advice in childhood atopic dermatitis. J Invest Dermatol 117(4):852–857
Santer M, Burgess H, Yardley L, Ersser SJ, Lewis-Jones S, Muller I et al (2013) Managing childhood eczema: qualitative study exploring carers’ experiences of barriers and facilitators to treatment adherence. J Adv Nurs 69(11):2493–2501
Tuft L (1979) «Steroid-phobia» in asthma management. Ann Allergy 42(3):152–159
David TJ (1987) Steroid scare. Arch Dis Child 62(9):876–878
Patterson R, Walker CL, Greenberger PA, Sheridan EP (1989) Prednisonephobia. Allergy Proc Off J Reg State Allergy Soc 10(6):423–428
Fischer G (1996) Compliance problems in paediatric atopic eczema. Australas J Dermatol 37(Suppl 1):S10–S13
Charman CR, Morris AD, Williams HC (2000) Topical corticosteroid phobia in patients with atopic eczema. Br J Dermatol 142(5):931–936
Hon K-LE, Kam W-YC, Leung T-F, Lam M-CA, Wong K-Y, Lee K-CK et al (2006) Steroid fears in children with eczema. Acta Paediatr Oslo Nor 1992 95(11):1451–1455
Kojima R, Fujiwara, Matsuda, Narita, Matsubara. Factors associated with steroid pho… [Pediatr Dermatol. 2013 Jan-Feb] – PubMed – NCBI [Internet]. [cité 20 janv 2014]. Disponible sur: http://www.ncbi.nlm.nih.gov/pubmed/22747965
Aubert-Wastiaux H, Moret L, Le Rhun A, Fontenoy AM, Nguyen JM, Leux C et al (2011) Topical corticosteroid phobia in atopic dermatitis: a study of its nature, origins and frequency. Br J Dermatol 165(4):808–814
Brown KL, Krejci-Manwaring J, Tusa MG, Camacho F, Fleischer AB, Balkrishnan R et al (2008) Poor compliance with topical corticosteroids for atopic dermatitis despite severe disease. Dermatol Online J 14(9):13
Thomas KS, Armstrong S, Avery A, Po ALW, O’Neill C, Young S et al (2002) Randomised controlled trial of short bursts of a potent topical corticosteroid versus prolonged use of a mild preparation for children with mild or moderate atopic eczema. BMJ 324(7340):768
Van Der Meer JB, Glazenburg EJ, Mulder PG, Eggink HF, Coenraads PJ (1999) The management of moderate to severe atopic dermatitis in adults with topical fluticasone propionate. The Netherlands Adult Atopic Dermatitis Study Group. Br J Dermatol 140(6):1114–1121
Davis SA, Lin H-C, Yu C-H, Balkrishnan R, Feldman SR (2014) Underuse of early follow-up visits: a missed opportunity to improve patients’ adherence. J Drugs Dermatol JDD 13(7):833–836
Shah A, Yentzer BA, Feldman SR (2013) Timing of return office visit affects adherence to topical treatment in patients with atopic dermatitis: an analysis of 5 studies. Cutis 91(2):105–107
Carroll CL, Feldman SR, Camacho FT, Manuel JC, Balkrishnan R (2004) Adherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: commonly used methods of measuring adherence to topical therapy overestimate actual use. J Am Acad Dermatol 51(2):212–216
Feldman SR, Camacho FT, Krejci-Manwaring J, Carroll CL, Balkrishnan R (2007) Adherence to topical therapy increases around the time of office visits. J Am Acad Dermatol 57(1):81–83
Trookman NS, Rizer RL, Ho ET, Ford RO, Gotz V (2011) The importance of vehicle properties to patients with atopic dermatitis. Cutis 88(1 Suppl):13–17
Eastman WJ, Malahias S, Delconte J, DiBenedetti D (2014) Assessing attributes of topical vehicles for the treatment of acne, atopic dermatitis, and plaque psoriasis. Cutis 94(1):46–53
Barbarot S, Bernier C, Deleuran M, De Raeve L, Eichenfield L, El Hachem M et al (2013) Therapeutic patient education in children with atopic dermatitis: position paper on objectives and recommendations. Pediatr Dermatol 30(2):199–206
Chisolm SS, Taylor SL, Balkrishnan R, Feldman SR (2008) Written action plans: potential for improving outcomes in children with atopic dermatitis. J Am Acad Dermatol 59(4):677–683
Cork MJ, Britton J, Butler L, Young S, Murphy R, Keohane SG. Comparison of parent knowledge, therapy utilization and severity of atopic eczema before and after explanation and demonstration of topical therapies by a specialist dermatology nurse. Br J Dermatol 2003;149(3):582–9
Bewley A, Dermatology Working Group (2008) Expert consensus: time for a change in the way we advise our patients to use topical corticosteroids. Br J Dermatol 158(5):917–920
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Aubert, H., Barbarot, S. (2016). Adherence in Atopic Dermatitis. In: Davis, S. (eds) Adherence in Dermatology. Adis, Cham. https://doi.org/10.1007/978-3-319-30994-1_11
Download citation
DOI: https://doi.org/10.1007/978-3-319-30994-1_11
Published:
Publisher Name: Adis, Cham
Print ISBN: 978-3-319-30992-7
Online ISBN: 978-3-319-30994-1
eBook Packages: MedicineMedicine (R0)